CAS: 100502-66-7; Abrucomstat

该化合物是一种有机化合物,其特征是硝基化合物和三碳丙烷主干柱的氢氧基化合物,该化合物一般是无色的,淡黄色的液体,可溶于水中,因为氢氧化物组会增加其极分性.硝基丙醇组有助于其反应,使其有可能成为各种化学反应,包括硝化和减少过程的候选体.3-硝基丙醇可能呈现出诸如血压学等特性,这意味着它可以吸收空气的湿气.其应用范围从有机合成用途到制药或农用化学品的潜在作用,尽管根据进一步研发情况,具体应用可能有所不同.应参考安全数据了解其毒性和处理防范措施,因为含有硝基化合物的化合物有时会构成健康风险.

结构式图片

欧盟法规

C&L通报

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-7211590-B2
    优先权日:2002-08-01
    标 题:Nitrosated proton pump inhibitors, compositions and methods of use
    发明人:FANG XINQIN; GARVEY DAVID S; LETTS L GORDON
    权利人:NITROMED INC
    摘要:The invention describes novel nitrosated proton pump inhibitor compounds and pharmaceutically acceptable salts thereof, and novel compositions comprising at least one nitrosated proton pump inhibitor compound, and, optionally, at least one compound that donates, transfers or releases nitric oxide, stimulates endogenous synthesis of nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor or is a substrate for nitric oxide synthase, and/or at least one therapeutic agent. The invention also provides novel compositions comprising at least one nitrosated proton pump inhibitor compound, and at least one compound that donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase and/or at least one therapeutic agent. The invention also provides novel kits comprising at least one nitrosated proton pump inhibitor compound, and, optionally, at least one nitric oxide donor and/or at least one therapeutic agent. The invention also provides methods for treating gastrointestinal disorders; facilitating ulcer healing; decreasing the recurrence of ulcers; improving gastroprotective properties, anti-Helicobacter pylori properties or antacid properties of proton pump inhibitors; decreasing or reducing the gastrointestinal toxicity associated with the use of nonsteroidal antiinflammatory compounds; treating bacterial infections and/or viral infections.

    专利号:US-8304409-B2
    优先权日:2002-07-03
    标 题:Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
    发明人:EARL RICHARD A; EZAWA MAIKO; FANG XINQIN; GARVEY DAVID S; GASTON RICKY D; KHANAPURE SUBHASH P; LETTS L GORDON; LIN CHIA-EN; RANATUNGE RAMANI R; RICHARDSON STEWART K; SCHROEDER JOSEPH D; STEVENSON CHERI A; WEY SHIOW-JYI
    权利人:EARL RICHARD A; EZAWA MAIKO; FANG XINQIN; GARVEY DAVID S; GASTON RICKY D; KHANAPURE SUBHASH P; LETTS L GORDON; LIN CHIA-EN; RANATUNGE RAMANI R; RICHARDSON STEWART K; SCHROEDER JOSEPH D; STEVENSON CHERI A; WEY SHIOW-JYI; NICOX SA
    摘要:The invention describes novel nitrosated nonsteroidal antiinflammatory drugs (NSAIDs) and pharmaceutically acceptable salts thereof, and novel compositions comprising at least one nitrosated NSAID, and, optionally, at least one compound that donates, transfers or releases nitric oxide, stimulates endogenous synthesis of nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor or is a substrate for nitric oxide synthase, and/or at least one therapeutic agent. The invention also provides novel compositions comprising at least one nitrosated NSAID, and at least one compound that donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase and/or at least one therapeutic agent. The invention also provides novel kits comprising at least one nitrosated NSAID, and, optionally, at least one nitric oxide donor and/or at least one therapeutic agent. The invention also provides methods for treating inflammation, pain and fever; for treating gastrointestinal disorders; for facilitating wound healing; for treating and/or preventing gastrointestinal, renal and/or respiratory toxicities resulting from the use of nonsteroidal antiinflammatory compounds; for treating inflammatory disease states and/or disorders; and for treating and/or preventing ophthalmic diseases and/or disorders.

    专利号:US-8030440-B1
    优先权日:2010-05-21
    标 题 :Synthesis of poly-(3-nitratooxetane)
    发明人:WILLER RODNEY L; BAUM KURT; LIN WEN-HUEY
    权利人:FLUOROCHEM INC
    摘要:3-nitratooxetane. n Poly-(3-nitratooxetane). n The method of synthesizing 3-nitratooxetane comprising reacting 3-hydroxyoxetane with a nitration agent. n The method of synthesizing poly-(3-nitratooxetane) by polymerizing 3-nitratooxetane using a polyol initiator.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Lokuge GMS, Larsen MK, Maigaard M, Wiking L, Larsen LB, Lund P, Poulsen NA. Effects of feeding whole-cracked rapeseeds, nitrate, and 3-nitrooxypropanol on protein composition, minerals, and vitamin B in milk from Danish Holstein cows. J Dairy Sci. 2024 Apr
    3:S0022-0302(24)00642-8. doi: 10.3168/jds.2023-24372. Epub ahead of print. 14(5):763. doi: 10.3390/ani14050763.
    4: Hodge I, Quille P, O'Connell S. A Review of Potential Feed Additives Intended for Carbon Footprint Reduction through Methane Abatement in Dairy Cattle. Animals (Basel). 2024 Feb 8;14(4):568. doi: 10.3390/ani14040568.

    合成参考文献


    参考文献:10.1186/s40104-017-0145-9
    摘要:Patra A, Park T, Kim M, Yu Z. Rumen methanogens and mitigation of methane emission by anti-methanogenic compounds and substances. Journal of Animal Science and Biotechnology. 2017 Jan 26;8(1):13. doi: 10.1186/s40104-017-0145-9.
    参考文献:10.1093/jas/skab081
    摘要:Zhang XM, Smith ML, Gruninger RJ, Kung L, Vyas D, McGinn SM, Kindermann M, Wang M, Tan ZL, Beauchemin KA. Combined effects of 3-nitrooxypropanol and canola oil supplementation on methane emissions, rumen fermentation and biohydrogenation, and total tract digestibility in beef cattle. J Anim Sci. 2021 Apr 01;99(4).
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知